Patent [Off Topic]

posted by Jaime_R – Barcelona, 2010-12-28 17:05 (5663 d 22:11 ago) – Posting: # 6348
Views: 11,729

Dear Phaneendra!

❝ As to my knowledge, a patent is the exclusive right given to the innovator for 20 years from the date of filing and NDA.


Have you read Helmut's post? The innovator's drug is patented, not the formulation (filed in the NDA). Another story are patented drug delivery systems, e.g. the OROS technology from Alza. You may come up with another formulation being BE to an OROS formulation (if the drug is off-patent, of course), but may not use the the same technology, which would be a patent infringement.

Regards, Jaime

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
261 visitors (0 registered, 261 guests [including 15 identified bots]).
Forum time: 16:16 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5